Results 271 to 280 of about 10,439,347 (402)

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Patient Preferences for Using Remote Care Technology in Heart Failure: Discrete Choice Experiment. [PDF]

JMIR Cardio
Al-Naher A, Downing J, Hughes D, Pirmohamed M.   +3 more
europepmc   +1 more source

Preferences for Subtyping Primary Aldosteronism: a Discrete Choice Experiment: Supplemental Material

Woode, Maame Esi, Chong, Winston, Ng, Elisabeth, Lu-Shirzard, Shanshan, Gwini, Stella May, Fuller, Peter, Yang, Jun, Chen, Gang   +7 more
openalex   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Correction: The impacts of product characteristics and regulatory environment on smokers' preferences for tobacco and alcohol: Evidence from a volumetric choice experiment. [PDF]

PLoS One
Ma S, Shang C, Do VV, Huang J, Pechacek TF, Weaver SR.   +5 more
europepmc   +1 more source

Patients’ preferences for atopic dermatitis treatments in Europe: a discrete choice experiment

Heinz, Katja C., Beaudart, Charlotte, De Greef, Axel, Vanhooteghem, Olivier, Gostynski, Antoni, Hiligsmann, Mickaël   +5 more
openalex   +1 more source

Estimating Ambiguity Aversion in a Portfolio Choice Experiment [PDF]

David Ahn, Douglas Gale, Shachar Kariv, Syngjoo Choi   +3 more
core  

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Understanding preferences for self-sampling in a national cervical screening programme: a protocol for a discrete choice experiment. [PDF]

BMJ Open
Thapa S, Davies JC, Crosbie EJ, Payne K, Wright S.   +4 more
europepmc   +1 more source